vs
JFrog Ltd（FROG）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是JFrog Ltd的1.4倍（$197.9M vs $145.3M），REPLIGEN CORP净利率更高（6.7% vs -10.5%，领先17.2%），JFrog Ltd同比增速更快（25.2% vs 13.6%），JFrog Ltd自由现金流更多（$49.9M vs $17.6M），过去两年JFrog Ltd的营收复合增速更高（20.4% vs 14.4%）
JFrog Ltd是全球知名的DevOps技术服务商，面向科技、金融、零售、制造等多个行业客户，提供全链路软件发布、制品管理与安全解决方案，助力企业简化云、本地及混合部署环境下的应用开发与交付流程。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FROG vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$145.3M
营收增速更快
FROG
高出11.5%
13.6%
净利率更高
RGEN
高出17.2%
-10.5%
自由现金流更多
FROG
多$32.3M
$17.6M
两年增速更快
FROG
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $145.3M | $197.9M |
| 净利润 | $-15.2M | $13.3M |
| 毛利率 | 77.9% | 52.5% |
| 营业利润率 | -14.7% | 9.0% |
| 净利率 | -10.5% | 6.7% |
| 营收同比 | 25.2% | 13.6% |
| 净利润同比 | 34.4% | 143.9% |
| 每股收益（稀释后） | $-0.13 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FROGRGEN
| Q4 25 | $145.3M | $197.9M | ||
| Q3 25 | $136.9M | $188.8M | ||
| Q2 25 | $127.2M | $182.4M | ||
| Q1 25 | $122.4M | $169.2M | ||
| Q4 24 | $116.1M | $174.1M | ||
| Q3 24 | $109.1M | $154.9M | ||
| Q2 24 | $103.0M | $154.1M | ||
| Q1 24 | $100.3M | $151.3M |
净利润FROGRGEN
| Q4 25 | $-15.2M | $13.3M | ||
| Q3 25 | $-16.4M | $14.9M | ||
| Q2 25 | $-21.7M | $14.9M | ||
| Q1 25 | $-18.5M | $5.8M | ||
| Q4 24 | $-23.2M | $-30.3M | ||
| Q3 24 | $-22.9M | $-654.0K | ||
| Q2 24 | $-14.3M | $3.3M | ||
| Q1 24 | $-8.8M | $2.1M |
毛利率FROGRGEN
| Q4 25 | 77.9% | 52.5% | ||
| Q3 25 | 77.4% | 53.2% | ||
| Q2 25 | 76.3% | 50.0% | ||
| Q1 25 | 75.3% | 53.6% | ||
| Q4 24 | 75.4% | 26.1% | ||
| Q3 24 | 75.0% | 50.0% | ||
| Q2 24 | 78.8% | 49.8% | ||
| Q1 24 | 79.5% | 49.5% |
营业利润率FROGRGEN
| Q4 25 | -14.7% | 9.0% | ||
| Q3 25 | -15.8% | 8.9% | ||
| Q2 25 | -20.4% | 7.6% | ||
| Q1 25 | -18.8% | 3.9% | ||
| Q4 24 | -21.9% | -17.7% | ||
| Q3 24 | -27.4% | -5.1% | ||
| Q2 24 | -18.6% | 1.0% | ||
| Q1 24 | -16.6% | 1.3% |
净利率FROGRGEN
| Q4 25 | -10.5% | 6.7% | ||
| Q3 25 | -12.0% | 7.9% | ||
| Q2 25 | -17.0% | 8.2% | ||
| Q1 25 | -15.1% | 3.4% | ||
| Q4 24 | -20.0% | -17.4% | ||
| Q3 24 | -21.0% | -0.4% | ||
| Q2 24 | -13.9% | 2.2% | ||
| Q1 24 | -8.8% | 1.4% |
每股收益（稀释后）FROGRGEN
| Q4 25 | $-0.13 | $0.24 | ||
| Q3 25 | $-0.14 | $0.26 | ||
| Q2 25 | $-0.19 | $0.26 | ||
| Q1 25 | $-0.16 | $0.10 | ||
| Q4 24 | $-0.21 | $-0.55 | ||
| Q3 24 | $-0.21 | $-0.01 | ||
| Q2 24 | $-0.13 | $0.06 | ||
| Q1 24 | $-0.08 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $704.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $887.4M | $2.1B |
| 总资产 | $1.3B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FROGRGEN
| Q4 25 | $704.4M | $767.6M | ||
| Q3 25 | $651.1M | $748.7M | ||
| Q2 25 | $611.7M | $708.9M | ||
| Q1 25 | $563.5M | $697.2M | ||
| Q4 24 | $522.0M | $757.4M | ||
| Q3 24 | $467.8M | $784.0M | ||
| Q2 24 | $591.3M | $809.1M | ||
| Q1 24 | $579.6M | $780.6M |
总债务FROGRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FROGRGEN
| Q4 25 | $887.4M | $2.1B | ||
| Q3 25 | $859.4M | $2.1B | ||
| Q2 25 | $826.5M | $2.1B | ||
| Q1 25 | $800.0M | $2.0B | ||
| Q4 24 | $773.5M | $2.0B | ||
| Q3 24 | $756.2M | $2.0B | ||
| Q2 24 | $721.4M | $2.0B | ||
| Q1 24 | $707.8M | $2.0B |
总资产FROGRGEN
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.3B | $2.9B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $1.1B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.0B | $2.9B | ||
| Q1 24 | $997.1M | $2.8B |
负债/权益比FROGRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $50.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $49.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 34.3% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $142.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流FROGRGEN
| Q4 25 | $50.7M | $25.7M | ||
| Q3 25 | $30.2M | $48.1M | ||
| Q2 25 | $36.1M | $28.6M | ||
| Q1 25 | $28.8M | $15.0M | ||
| Q4 24 | $49.1M | $39.2M | ||
| Q3 24 | $27.6M | $49.3M | ||
| Q2 24 | $16.7M | $42.2M | ||
| Q1 24 | $17.5M | $44.7M |
自由现金流FROGRGEN
| Q4 25 | $49.9M | $17.6M | ||
| Q3 25 | $28.8M | $43.4M | ||
| Q2 25 | $35.5M | $21.5M | ||
| Q1 25 | $28.1M | $11.4M | ||
| Q4 24 | $48.5M | $33.6M | ||
| Q3 24 | $26.7M | $42.3M | ||
| Q2 24 | $16.0M | $37.4M | ||
| Q1 24 | $16.6M | $36.4M |
自由现金流率FROGRGEN
| Q4 25 | 34.3% | 8.9% | ||
| Q3 25 | 21.0% | 23.0% | ||
| Q2 25 | 27.9% | 11.8% | ||
| Q1 25 | 23.0% | 6.8% | ||
| Q4 24 | 41.8% | 19.3% | ||
| Q3 24 | 24.5% | 27.3% | ||
| Q2 24 | 15.5% | 24.3% | ||
| Q1 24 | 16.6% | 24.0% |
资本支出强度FROGRGEN
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 1.0% | 2.5% | ||
| Q2 25 | 0.5% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | 0.7% | 3.1% | ||
| Q1 24 | 0.8% | 5.5% |
现金转化率FROGRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
